Krackeler Scientific Makes First Corporate Gift to The RNA Institute at the University at Albany
Krackeler Scientific President and CEO Anthony Krackeler. (Photo Mark Schmidt)
ALBANY, N.Y. (November 10, 2010) --
Krackeler Scientific, Inc., an Albany-based distributor of scientific products, has made the first corporate gift to The RNA Institute at the University at Albany. The gift totals $45,000.
"Private investment in research and training for technology commercialization at public institutions – like this gift -- is essential to the success of The RNA Institute," said Institute Director Paul F. Agris. "These types of contributions fuel the economic engine of research institutions, and the return on such an investment is very high."
"We are grateful for Krackeler Scientific's support of The RNA Institute. Their philanthropic investment will enhance the Institute's ability to be a resource for small, medium and large biomedical businesses and spur economic growth in our community," said UAlbany President George M. Philip.
The RNA Institute, which was launched in June, brings together leading researchers from higher education and other institutions, and offers advanced facilities for RNA-based drug discovery. The goal is to advance research into RNA and its implications for innovative medicines, drug therapies and technologies to cure disease.
The RNA Institute received a major boost this month with the award of $7.4 million in new federal and state funding to finance the design, engineering and construction of a research center similar to those found in modern pharmaceutical companies. The facility will feature open, interactive space to promote collaboration and synergies, and sustainability built into the complete mobility of laboratory benches and walls.
Another indication of the Institute’s growing profile in the field of RNA-based research is the establishment of the RNA MassSpec Center, dedicated to the development of MassSpec-based technologies for investigating the structure-function relationships of natural and synthetic RNA as tools for drug discovery. The center features world-class instrumentation.
"We are excited by what we see as the Institute's unique potential for advancing cutting-edge RNA research and applications, as well as its clear and substantial enhancement of the growing life science research profile of New York's Capital Region," said Krackeler Scientific President and CEO Anthony R. Krackeler.
Krackeler Scientific serves customers in biotechnology, nanotechnology, life sciences, pharmaceutical, biomedical, environmental, and industrial sectors. Next year the firm celebrates its 60th year in business.
For more news, subscribe to UAlbany's RSS headline feeds
Educationally and culturally, the University at Albany-SUNY puts "The World Within Reach" for its 18,000 students. An internationally recognized research university with 58 undergraduate majors and 128 graduate degree programs, UAlbany is a leader among all New York State colleges and universities in such diverse fields as public policy, nanotechnology and criminal justice. With a curriculum enhanced by 300 study-abroad opportunities, UAlbany launches great careers. For more information about this globally ranked University, visit http://www.albany.edu/. For UAlbany's extensive roster of faculty experts, visit www.albany.edu/news/experts.shtml.